Share Facebook Twitter LinkedIn Pinterest Email WhatsApp Canada has approved Pfizer’s antiviral pill Paxlovid for the treatment of COVID-19 amid rising virus cases in the country. The oral drug has been authorized to treat mild-to-moderate COVID-19 in adults.